Healthcare -
Biotechnology - NASDAQ - US
$ 6.19
-2.37 %
$ 45.2 M
Market Cap
-0.47
P/E
Price Target
Average
114.05%
Revenue Forecast
Estimate
65.10%
EBIT
Estimate
29.66%
Net Income
Estimate
--64.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kezar Life Sciences, Inc.
Wall Street analysts predict an average 1-year price target for KZR of $13.2 , with forecasts ranging from
a
low of
$9 to a high of $21 .
KZR Lowest Price Target
Wall Street Target
9 USD
45.40%
KZR Average Price Target
Wall Street Target
13.2 USD
114.05%
KZR Highest Price Target
Wall Street Target
21 USD
239.26%
REVENUE FORECAST
Revenue Forecast Chart KZR
EBIT FORECAST
EBIT Forecast Chart KZR
NET INCOME FORECAST
Net Income Chart KZR